Clinical Trial Update: Mechanism Study of Sulforaphane in ASD Improvement [NA]

View source ↗

Summary

A clinical trial investigating the mechanism by which sulforaphane could affect Autism Spectrum Disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Sulforaphane (sulforaphane)

Snippet

Sponsor: Jian-Jun Ou | Conditions: Autism Spectrum Disorder, Sulforaphane | NA | Status: WITHDRAWN